Darlene Noci
Corporate Officer/Principal at NUVALENT, INC.
Net worth: 3 M $ as of 2024-06-29
Darlene Noci active positions
Companies | Position | Start | End |
---|---|---|---|
NUVALENT, INC. | Corporate Officer/Principal | 2022-07-19 | - |
General Counsel | 2020-12-31 | 2022-07-19 |
Career history of Darlene Noci
Former positions of Darlene Noci
Companies | Position | Start | End |
---|---|---|---|
X4 PHARMACEUTICALS, INC. | General Counsel | 2015-12-31 | 2018-04-30 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Corporate Officer/Principal | 2014-05-31 | 2015-12-31 |
Noci Strategic Consulting LLC | Founder | 2018-04-30 | - |
AVEO PHARMACEUTICALS, INC. | General Counsel | - | - |
Training of Darlene Noci
Adelphi University | Undergraduate Degree |
Harvard University | Graduate Degree |
Statistics
International
United States | 8 |
Operational
General Counsel | 3 |
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 5 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
X4 PHARMACEUTICALS, INC. | Health Technology |
NUVALENT, INC. | Health Technology |
Private companies | 3 |
---|---|
AVEO Pharmaceuticals, Inc.
AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA. | Health Technology |
Noci Strategic Consulting LLC | |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
- Stock Market
- Insiders
- Darlene Noci
- Experience